Anne Marie Comeau to United States
This is a "connection" page, showing publications Anne Marie Comeau has written about United States.
Connection Strength
0.155
-
Pass K, Green NS, Lorey F, Sherwin J, Comeau AM. Pilot programs in newborn screening. Ment Retard Dev Disabil Res Rev. 2006; 12(4):293-300.
Score: 0.024
-
Parad RB, Comeau AM. Newborn screening for cystic fibrosis. Pediatr Ann. 2003 Aug; 32(8):528-35.
Score: 0.021
-
Ream MA, Lam WKK, Grosse SD, Ojodu J, Jones E, Prosser LA, Ros? AM, Comeau AM, Tanksley S, Powell CM, Kemper AR. Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States. Genet Med. 2023 02; 25(2):100330.
Score: 0.020
-
Kemper AR, Brosco J, Comeau AM, Green NS, Grosse SD, Jones E, Kwon JM, Lam WK, Ojodu J, Prosser LA, Tanksley S. Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Genet Med. 2017 01; 19(1):121-126.
Score: 0.013
-
Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, Baker M, Ballow M, Bartoshesky LE, Bonilla FA, Brokopp C, Brooks E, Caggana M, Celestin J, Church JA, Comeau AM, Connelly JA, Cowan MJ, Cunningham-Rundles C, Dasu T, Dave N, De La Morena MT, Duffner U, Fong CT, Forbes L, Freedenberg D, Gelfand EW, Hale JE, Hanson IC, Hay BN, Hu D, Infante A, Johnson D, Kapoor N, Kay DM, Kohn DB, Lee R, Lehman H, Lin Z, Lorey F, Abdel-Mageed A, Manning A, McGhee S, Moore TB, Naides SJ, Notarangelo LD, Orange JS, Pai SY, Porteus M, Rodriguez R, Romberg N, Routes J, Ruehle M, Rubenstein A, Saavedra-Matiz CA, Scott G, Scott PM, Secord E, Seroogy C, Shearer WT, Siegel S, Silvers SK, Stiehm ER, Sugerman RW, Sullivan JL, Tanksley S, Tierce ML, Verbsky J, Vogel B, Walker R, Walkovich K, Walter JE, Wasserman RL, Watson MS, Weinberg GA, Weiner LB, Wood H, Yates AB, Puck JM, Bonagura VR. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014 Aug 20; 312(7):729-38.
Score: 0.011
-
Kemper AR, Green NS, Calonge N, Lam WK, Comeau AM, Goldenberg AJ, Ojodu J, Prosser LA, Tanksley S, Bocchini JA. Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. Genet Med. 2014 Feb; 16(2):183-7.
Score: 0.010
-
Kemper AR, Kus CA, Ostrander RJ, Comeau AM, Boyle CA, Dougherty D, Mann MY, Botkin JR, Green NS. A framework for key considerations regarding point-of-care screening of newborns. Genet Med. 2012 Dec; 14(12):951-4.
Score: 0.010
-
Comeau AM, Harris JA, McIntosh K, Weiblen BJ, Hoff R, Grady GF. Polymerase chain reaction in detecting HIV infection among seropositive infants: relation to clinical status and age and to results of other assays. J Acquir Immune Defic Syndr (1988). 1992; 5(3):271-8.
Score: 0.009
-
Kemper AR, Knapp AA, Metterville DR, Comeau AM, Green NS, Perrin JM. Weighing the evidence for newborn screening for Hemoglobin H disease. J Pediatr. 2011 May; 158(5):780-3.
Score: 0.009
-
Kemper AR, Knapp AA, Green NS, Comeau AM, Metterville DR, Perrin JM. Weighing the evidence for newborn screening for early-infantile Krabbe disease. Genet Med. 2010 Sep; 12(9):539-43.
Score: 0.008
-
Perrin JM, Knapp AA, Browning MF, Comeau AM, Green NS, Lipstein EA, Metterville DR, Prosser L, Queally D, Kemper AR. An evidence development process for newborn screening. Genet Med. 2010 Mar; 12(3):131-4.
Score: 0.008
-
Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep. 2004 Oct 15; 53(RR-13):1-36.
Score: 0.006
-
Eaton RB, Comeau AM, Zytkovicz TH, Larson C. Newborn screening: new developments in a proven field. Clin Lab Sci. 2002; 15(4):239-44.
Score: 0.005
-
McIntosh K, Comeau AM, Wara D, Diaz C, Landesman S, Pitt J, Rich K, Lew J, Moye J, Kalish LA. The utility of IgA antibody to human immunodeficiency virus type 1 in early diagnosis of vertically transmitted infection. National Institute of Allergy and Infectious Diseases and National Institute of Child Health and Human Development Women and Infants Transmission Study Group. Arch Pediatr Adolesc Med. 1996 Jun; 150(6):598-602.
Score: 0.003